Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2924 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2017-04-03 | 2019-01-03 | 5192 |
| TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2019-10-03 | 2019-10-10 | 95370 |
| TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2022-09-07 | 2023-10-05 | 168733 |
| TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-02-09 | 2024-05-30 | 184216 |
| TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-06-16 | 2023-07-05 | 195164 |
| TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-06-20 | 2023-07-05 | 195775 |
| TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-10-19 | 2024-04-11 | 207548 |
| TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Actual shortage | 2025-10-30 | 2025-11-20 | 270669 |
| TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Actual shortage | 2025-12-04 | 2025-12-04 | 273308 |
| TEVA-ECTOSONE | 0.1% | CREAM | Resolved | 2020-03-19 | 2020-07-09 | 109053 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2020-03-26 | 2020-04-23 | 109601 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2020-09-24 | 2020-10-01 | 124953 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2021-03-25 | 2021-04-01 | 136300 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2021-07-29 | 2021-09-30 | 143242 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2021-08-27 | 2023-12-05 | 144715 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2022-09-22 | 2022-12-22 | 169957 |
| TEVA-ECTOSONE | 0.1% | CREAM | Resolved | 2022-12-22 | 2023-12-14 | 179180 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2023-04-27 | 2023-07-05 | 190689 |
| TEVA-ECTOSONE | 0.05% | CREAM | Resolved | 2023-06-08 | 2023-11-16 | 194068 |
| TEVA-ECTOSONE | 0.05% | LOTION | Resolved | 2023-06-08 | 2024-03-07 | 194074 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ENALAPRIL | 8MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258676 |
| ACT ENALAPRIL | 4MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258682 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2019-02-21 | 2019-03-01 | 76486 |
| ACT FLUCONAZOLE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258697 |
| ACT FLUCONAZOLE | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258703 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104304 |
| TEVA-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266377 |
| TEVA-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266380 |
| TEVA-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266383 |
| ACT NABILONE | 1MG | CAPSULE | Discontinued | 2019-10-31 | 2019-11-01 | 97581 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| TEVA-OLMESARTAN | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117497 |